Effectiveness and cost-benefit of influenza vaccination of healthy working adults: A randomized controlled trial.
By C. Bridges, W. Thompson, M. Meltzer, G. Reeve, W. Talamonti, N. Cox, Heather A. Lilac, H. Hall, A. Klimov, K. Fukuda. Journal of the American Medical Association (JAMA), 2000
691 citations recorded by the source corpus.
Subfields: Epidemiology, Pulmonary and Respiratory Medicine
View Paper: https://www.semanticscholar.org/paper/de722ef0c9a4afeb2ca1483e64da84fbe3efd6ed
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
- A. García‐Sastre
- P. Palese
- J. Steel
- Anice C. Lowen
- Raymond Tellier
- J. Tang
- Jeffrey Shaman
- J. Taubenberger
Citations in the corpus
- The annual impact of seasonal influenza in the US: measuring disease burden and costs. (2007, neutral): “[5] Bridges CB, Thompson WW, Meltzer MI, Reeve GR, Talamonti WJ, Cox NJ, et al.”
- Antibody landscapes after influenza virus infection or vaccination (2014, neutral): “Consequently, such vaccines have poor effectiveness in this mismatch situation (23-26).”
- Influenza Virus Vaccine Based on the Conserved Hemagglutinin Stalk Domain (2010, background): “Unfortunately, the predictions of the vaccine strain selection committee can be inaccurate, resulting in a substantial drop in the efficacy of vaccination (7, 8).”
- Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. (2009, background): “However, even during years when vaccine strains were not antigenically well matched to circulating strains (the result of antigenic drift), substantial protection has been observed against severe outcomes, presumably because of vaccine-induced cross-reacting antibodies (121,125,222,283).”